Tumor budding in colorectal cancer—ready for diagnostic practice?

VH Koelzer, I Zlobec, A Lugli - Human pathology, 2016 - Elsevier
Tumor budding is an important additional prognostic factor for patients with colorectal cancer
(CRC). Defined as the presence of single tumor cells or small clusters of up to 5 cells in the …

Current problems and perspectives of pathological risk factors for lymph node metastasis in T1 colorectal cancer: Systematic review

K Ichimasa, S Kudo, H Miyachi, Y Kouyama… - Digestive …, 2022 - Wiley Online Library
With the prevalence of endoscopic submucosal dissection and endoscopic full thickness
resection, which enable complete resection of T1 colorectal cancer with a negative margin …

[HTML][HTML] Deep submucosal invasion is not an independent risk factor for lymph node metastasis in T1 colorectal cancer: a meta-analysis

LW Zwager, BAJ Bastiaansen, NSM Montazeri… - Gastroenterology, 2022 - Elsevier
Background & Aims Deep submucosal invasion (DSI) is considered a key risk factor for
lymph node metastasis (LNM) and important criterion to recommend surgery in T1 colorectal …

Molecular profiling of tumour budding implicates TGFβ‐mediated epithelial–mesenchymal transition as a therapeutic target in oral squamous cell carcinoma

DH Jensen, E Dabelsteen, L Specht… - The Journal of …, 2015 - Wiley Online Library
Although tumour budding is an adverse prognostic factor for many cancer types, the
molecular mechanisms governing this phenomenon are incompletely understood …

Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis

R Cappellesso, C Luchini, N Veronese, ML Mele… - Human pathology, 2017 - Elsevier
Worldwide, colorectal cancer (CRC) screening programs have significantly increased the
detection of submucosal (pT1) adenocarcinoma. Completion surgery may be indicated after …

Tumor budding in colorectal carcinoma: translating a morphologic score into clinically meaningful results

SJ Cho, S Kakar - Archives of pathology & laboratory …, 2018 - meridian.allenpress.com
Context.—Tumor budding has received increasing recognition as an important independent
prognostic factor in colorectal carcinoma. Prominent tumor budding in adenocarcinoma …

[HTML][HTML] Controversies in the pathological assessment of colorectal cancer

A Maguire, K Sheahan - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Pathologic assessment of colorectal cancer specimens plays an essential role in patient
management, informing prognosis and contributing to therapeutic decision making. The …

[HTML][HTML] Early stage colon cancer

HJ Freeman - World journal of gastroenterology: WJG, 2013 - ncbi.nlm.nih.gov
Evidence has now accumulated that colonoscopy and removal of polyps, especially during
screening and surveillance programs, is effective in overall risk reduction for colon cancer …

CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer

S Ni, F Ren, M Xu, C Tan, W Weng, Z Huang… - Cancer …, 2018 - Wiley Online Library
Collagen triple helix repeat containing (CTHRC1), which was identified as a cancer‐related
factor, is a promigratory protein involved in multiple processes, including vascular …

Classic and novel histopathologic risk factors for lymph node metastasis in T1 colorectal cancer: a systematic review and meta-analysis

MA Dykstra, TI Gimon, PE Ronksley… - Diseases of the Colon …, 2021 - journals.lww.com
BACKGROUND: Treatment of endoscopically resected T1 colorectal cancers is based on
the risk of lymph node metastasis. Risk is based on histopathologic features, although there …